Tyrrell, J., Richmond, R. C., Palmer, T. M., Feenstra, B...
Transcript of Tyrrell, J., Richmond, R. C., Palmer, T. M., Feenstra, B...
Tyrrell, J., Richmond, R. C., Palmer, T. M., Feenstra, B., Rangarajan, J.,Metrusky, S., ... Freathy, R. M. (2016). Genetic Evidence for CausalRelationships Between Maternal Obesity-Related Traits and Birth Weight.JAMA - Journal of the American Medical Association, 315(11), 1129-1140.https://doi.org/10.1001/jama.2016.1975
Peer reviewed version
Link to published version (if available):10.1001/jama.2016.1975
Link to publication record in Explore Bristol ResearchPDF-document
University of Bristol - Explore Bristol ResearchGeneral rights
This document is made available in accordance with publisher policies. Please cite only the publishedversion using the reference above. Full terms of use are available:http://www.bristol.ac.uk/pure/about/ebr-terms
1
Dateofrevision:11February2016
Wordcount(text):3837
Geneticevidenceforcausalrelationshipsbetweenmaternalobesity-related
traitsandbirthweight
JessicaTyrrell,PhD1,2;RebeccaC.Richmond,PhD3,4,12;TomM.Palmer,PhD5,6*;BjarkeFeenstra,
PhD7;JananiRangarajan,MS8;SarahMetrustry,MSc9;AlanaCavadino,MSc10,11;LaviniaPaternoster,
PhD12;LorenL.Armstrong,PhD13;N.ManekaG.DeSilva,PhD12;AndrewR.Wood,PhD1;Momoko
Horikoshi,MD,PhD14,15;FrankGeller,MSc7;RonnyMyhre,PhD16;JonathanP.Bradfield,BS17;Eskil
Kreiner-Møller,MD18;VilleHuikari,MSc19;JodieN.Painter,PhD20;Jouke-JanHottenga,PhD21,22;
CatherineAllard,BSc23,24;DianeJ.Berry,PhD11;LuigiBouchard,PhD,MBA24-26;ShiktaDas,PhD27;
DavidM.Evans,PhD3,12,28;HakonHakonarson,MD,PhD17,29,30;M.GeoffreyHayes,PhD13;Jani
Heikkinen,MSc31;AlbertHofman,PhD32;BridgetKnight,PhD1;PenelopeA.Lind,PhD20;MarkI.
McCarthy,MD,PhD14,15,33;GeorgeMcMahon,PhD3;SarahE.Medland,PhD20;MadsMelbyeMD,
DMSc7,34;AndrewP.Morris,PhD15,35;MichaelNodzenski,MS8;ChristophReichetzeder,MD36,37;
SusanM.Ring,PhD3,12;SylvainSebert,PhD19,38;VerenaSengpiel,PhD39;ThorkildI.A.Sørensen,
MD12,40,41;GonnekeWillemsen,PhD21,22;EcoJ.C.deGeus,PhD21,22;NicholasG.Martin,PhD20;Tim
D.Spector,MD9;ChristinePower,PhD11;Marjo-RiittaJärvelin,MD,PhD19,38,42-44;HansBisgaard,MD,
DMSci18;StruanF.A.Grant,PhD17,29,30;EllenA.Nohr,PhD45;VincentW.Jaddoe,PhD4,32,46;Bo
Jacobsson,MD,PhD16,39;JeffreyC.Murray,MD47;BertholdHocher,MD,PhD36,48;AndrewT.
Hattersley,DM1;DeniseM.Scholtens,PhD8;GeorgeDaveySmith,DSc3,12;Marie-FranceHivert,
MD49-51;JanineF.Felix,PhD4,32,46;ElinaHyppönen,PhD11,52,53;WilliamL.Lowe,Jr.,MD13;TimothyM.
Frayling,PhD1*;DebbieA.Lawlor,PhD3,12*;andRachelM.Freathy,PhD1,12*fortheEarlyGrowth
Genetics(EGG)Consortium
1. InstituteofBiomedicalandClinicalScience,UniversityofExeterMedicalSchool,RoyalDevonand
ExeterHospital,BarrackRoad,Exeter,EX25DW,UK.2. EuropeanCentreforEnvironmentandHumanHealth,UniversityofExeter,TheKnowledgeSpa,
Truro,TR13HD.3. SchoolofSocialandCommunityMedicine,UniversityofBristol,OakfieldHouse,OakfieldGrove,
Bristol,BS82BN,UK.4. TheGenerationRStudyGroup,ErasmusMC,UniversityMedicalCenterRotterdam,P.O.Box2040,
3000CA,Rotterdam,theNetherlands.5. DivisionofHealthSciences,WarwickMedicalSchool,UniversityofWarwick,Coventry,UK.6. DepartmentofMathematicsandStatistics,LancasterUniversity,Lancaster,UK.7. DepartmentofEpidemiologyResearch,StatensSerumInstitut,Copenhagen,Denmark.
2
8. DepartmentofPreventiveMedicine,NorthwesternUniversityFeinbergSchoolofMedicine.9. DepartmentofTwinResearch,King'sCollegeLondon,St.Thomas'Hospital,London,UK.10. CentreforEnvironmentalandPreventiveMedicine,WolfsonInstituteofPreventiveMedicine,
BartsandtheLondonSchoolofMedicineandDentistry,QueenMaryUniversityofLondon.11. Population,PolicyandPractice,UCLInstituteofChildHealth,UniversityCollegeLondon,UK.12. MedicalResearchCouncilIntegrativeEpidemiologyUnitattheUniversityofBristol,UK.13. DivisionofEndocrinology,MetabolismandMolecularMedicine,NorthwesternUniversity
FeinbergSchoolofMedicine14. OxfordCentreforDiabetes,EndocrinologyandMetabolism,UniversityofOxford,UK.15. WellcomeTrustCentreforHumanGenetics,UniversityofOxford,Oxford,UK.16. DepartmentofGenesandEnvironment,DivisionofEpidemiology,NorwegianInstituteofPublic
Health,Oslo,Norway.17. CenterforAppliedGenomics,TheChildren’sHospitalofPhiladelphia,Philadelphia,Pennsylvania,
USA.18. CopenhagenProspectiveStudiesonAsthmainChildhood(COPSAC),FacultyofHealthSciences,
UniversityofCopenhagen,Copenhagen,Denmark&DanishPediatricAsthmaCenter,CopenhagenUniversityHospital,Gentofte,Denmark.
19. InstituteofHealthSciences,UniversityofOulu,Oulu,Finland20. QIMRBerghoferMedicalResearchInstitute,LockedBag2000,RoyalBrisbaneHospital,Herston,
Qld4029,Australia.21. EMGOInstituteforHealthandCareResearch,VUUniversityMedicalCenter,Amsterdam,The
Netherlands.22. DepartmentofBiologicalPsychology,VUUniversityAmsterdam,VanderBoechorststraat1,1081
BTAmsterdam,TheNetherlands.23. DepartmentofMathematics,UniversitedeSherbrooke,QC,Canada.24. CentrederechercheduCentreHospitalierUniversitairedeSherbrooke,Sherbrooke,QC,Canada.25. ECOGENE-21andLipidClinic,ChicoutimiHospital,Saguenay,QC,Canada.26. DepartmentofBiochemistry,UniversitédeSherbrooke,Sherbrooke,QC,Canada.27. DepartmentofPrimaryCareandPublicHealth,ImperialCollegeLondon.28. UniversityofQueenslandDiamantinaInstitute,TranslationalResearchInstitute,Brisbane,
Queensland,Australia.29. DivisionofHumanGenetics,TheChildren’sHospitalofPhiladelphia,Philadelphia,Pennsylvania,
USA.30. DepartmentofPediatrics,PerelmanSchoolofMedicine,UniversityofPennsylvania,Philadelphia,
Pennsylvania,USA.31. FIMMInstituteforMolecularMedicineFinland,HelsinkiUniversityHelsinki,FI-00014,Finland.32. DepartmentofEpidemiology,ErasmusMC,UniversityMedicalCenterRotterdam,P.O.Box2040,
3000CA,Rotterdam,theNetherlands.33. OxfordNationalInstituteforHealthResearch(NIHR)BiomedicalResearchCentre,Churchill
Hospital,Oxford,UK.34. DepartmentofMedicine,StanfordUniversitySchoolofMedicine,Stanford,California,USA.35. DepartmentofBiostatistics,UniversityofLiverpool,LiverpoolL693GA,UK.36. InstituteofNutritionalScience,UniversityofPotsdam,Germany37. CenterforCardiovascularResearch/Charité,Berlin,Germany.38. DepartmentofEpidemiologyandBiostatistics,SchoolofPublicHealth,MedicalResearch
Council-HealthProtectionAgencyCentreforEnvironmentandHealth,FacultyofMedicine,ImperialCollegeLondon,UK
39. DepartmentofObstetricsandGynecology,SahlgrenskaAcademy,SahgrenskaUniversityHospital,Gothenburg,Sweden.
40. InstituteofPreventiveMedicine,BispebjergandFrederiksbergUniversityHospital,CapitalRegion,Copenhagen,Denmark
41. NovoNordiskFoundationCenterforBasicMetabolicResearchandDepartmentofPublicHealth,FacultyofHealthandMedicalSciences,UniversityofCopenhagen,Copenhagen,Denmark
42. DepartmentofChildrenandYoungPeopleandFamilies,NationalInstituteforHealthandWelfare,Aapistie1,Box310,FI-90101Oulu,Finland.
43. BiocenterOulu,UniversityofOulu,Oulu,Finland.
3
44. UnitofPrimaryCare,OuluUniversityHospital,Kajaanintie50,P.O.Box20,FI-90220Oulu,90029OYS,Finland.
45. ResearchUnitofObstetrics&Gynecology,InstituteofClinicalResearch,UniversityofSouthernDenmark,Odense,Denmark.
46. DepartmentofPediatrics,ErasmusMC,UniversityMedicalCenterRotterdam,P.O.Box2040,3000CA,Rotterdam,theNetherlands.
47. DepartmentofPediatrics,UniversityofIowa,IowaCity,Iowa,USA.48. TheFirstAffiliatedHospitalofJinanUniversity,Guangzhou,510630,China.49. DepartmentofPopulationMedicine,HarvardPilgrimHealthCareInstitute,HarvardMedical
School,Boston,MA.50. DiabetesCenter,MassachussettsGeneralHospital,Boston,MA.51. DepartmentofMedicine,UniversitedeSherbrooke,QC,Canada.52. CentreforPopulationHealthResearch,SchoolofHealthSciences,andSansomInstitute,
UniversityofSouthAustralia,Adelaide,Australia.53. SouthAustralianHealthandMedicalResearchInstitute,Adelaide,Australia.
*Theseauthorsjointlydirectedthiswork
Correspondingauthors:Dr.RachelM.FreathyUniversityofExeterMedicalSchoolRoyalDevonandExeterHospitalBarrackRoadExeter,UKTel:+44(0)1392408238Email:r.freathy@ex.ac.ukProf.DebbieA.LawlorMRCIntegrativeEpidemiologyUnitattheUniversityofBristolOakfieldHouse,OakfieldRoad,Bristol,UKTel:+44(0)1173310096Email:d.a.lawlor@bristol.ac.ukProf.TimothyM.FraylingUniversityofExeterMedicalSchoolRoyalDevonandExeterHospitalBarrackRoadExeter,UKTel:+44(0)1392408256Email:[email protected]
4
Structuredabstract
Importance:Neonatesborntooverweight/obesewomenarelargerandathigherriskofbirth
complications.Manymaternalobesity-relatedtraitsareobservationallyassociatedwithbirth
weight,butthecausalnatureoftheseassociationsisuncertain.
Objective:Totestforgeneticevidenceofcausalassociationsofmaternalbodymassindex(BMI)and
relatedtraitswithbirthweight.
Design,SettingandParticipants:WeusedMendelianrandomizationtotestwhethermaternalBMI
andobesity-relatedtraitsarecausallyrelatedtooffspringbirthweight.Mendelianrandomization
makesuseofthefactthatgenotypesarerandomlydeterminedatconceptionandarethusnot
confoundedbynon-geneticfactors.Datawereanalysedon30,487womenfrom18studies.
ParticipantswereofEuropeanancestryfrompopulation-orcommunity-basedstudieslocatedin
Europe,NorthAmericaorAustraliaandparticipatingintheEarlyGrowthGenetics(EGG)
Consortium.Live,term,singletonoffspringbornbetween1929and2013wereincluded.Wetested
associationsbetweenageneticscoreof30BMI-associatedsinglenucleotidepolymorphisms(SNPs)
and(i)maternalBMIand(ii)birthweight,toestimatethecausalrelationshipbetweenBMIandbirth
weight.Analyseswererepeatedforotherobesity-relatedtraits.
Exposures:GeneticscoresforBMI,fastingglucoselevel,type2diabetes,systolicbloodpressure
(SBP),triglyceridelevel,HDL-cholesterollevel,vitaminDstatusandadiponectinlevel.
MainOutcome(s)andMeasure(s):Offspringbirthweightmeasuredbytrainedstudypersonnel(n=2
studies),frommedicalrecords(n=10studies)orfrommaternalreport(n=6studies).
Results:Amongthe30,487newbornsthemeanbirthweightinthevariouscohortsrangedfrom
3325gto3679g.ThegeneticscoreforBMIwasassociatedwitha2g(95%CI:0,3g)higheroffspring
birthweightpermaternalBMI-raisingallele(P=0.008).Thematernalgeneticscoresforfasting
glucoseandSBPwerealsoassociatedwithbirthweightwitheffectsizesof8g(95%CI:6,10g)per
5
glucose-raisingallele(P=7x10-14)and-4g(95%CI:-6,-2g)perSBP-raisingallele(P=1x10-5),
respectively.A1standarddeviation(1SD≈4kg/m2)geneticallyhighermaternalBMIwasassociated
witha55g(95%CI:17,93g)higherbirthweight.A1-SDgeneticallyhighermaternalfastingglucose
(≈0.4mmol/L)orSBP(10mmHg)wereassociatedwitha114g(95%CI:80,147g)higheror-208g(95%
CI:-394,-21g)lowerbirthweight,respectively.ForBMIandfastingglucosethesegenetic
associationswereconsistentwiththeobservationalassociations,butforSBP,thegeneticand
observationalassociationswereinoppositedirections.
ConclusionsandRelevance:InthisMendelianrandomizationstudyofmorethan30,000women
withsingletonoffspringfrom18studies,geneticallyelevatedmaternalBMIandbloodglucoselevels
werepotentiallycausallyassociatedwithhigheroffspringbirthweight,whereasgeneticallyelevated
maternalsystolicbloodpressurewasshowntobepotentiallycausallyrelatedtolowerbirthweight.
Ifreplicated,thesefindingsmayhaveimplicationsforcounselingandmanagingpregnanciestoavoid
adverseweight-relatedbirthoutcomes.
6
Introduction
Neonatesborntooverweightorobesewomenaremorelikelytobelargeforgestationalage.1The
precisemechanismsunderlyingthisassociationandtheextenttowhichconfoundingfactors
contributearepoorlyunderstood.Itisimportanttounderstandwhichmaternaltraitsarecausally
associatedwithbirthweightbecausethismay(i)facilitatetargeteddevelopmentofinterventionsto
betestedinrandomizedcontrolledtrials,and(ii)enableclear,evidence-basedrecommendationsin
pregnancy.
Maternaloverweightandobesityarekeyriskfactorsforgestationaldiabetes.2Evenintheabsence
ofdiabetes,obesewomenhavehigherglucoselevelsthannormalweightwomen,despitea
controlleddiet.3Theassociationbetweengestationaldiabetesandhigherbirthweightiswell
documented4,andmaternalglucoselevelsbelowthosediagnosticofdiabetesalsoshowstrong
associationswithbirthweight.5
Thefetusofanoverweightorobesewomanmaybeexposedtotheconsequencesofhigher
maternaltriglyceridelevelsandbloodpressure,lowerlevelsofHDL-cholesterol(HDLc)and
adiponectinandlowervitaminDstatus1,6,7(Box1).Thesematernalobesity-relatedtraitshavebeen
variablyassociatedwithbirthweightinobservationalstudies:highertriglyceridesandlowerHDLc
withhigherbirthweight8,9;higherbloodpressurewithlowerbirthweight10;lowervitaminDstatus
withlowerbirthweight11;andloweradiponectinwithhigherbirthweight12.However,associations
arenotalwaysconsistentlyobservedandmaybeconfounded,forexamplebymaternal
socioeconomicstatusandassociatedbehaviourssuchassmokinganddiet.Furthermore,thehigh
inter-correlationofobesity-relatedtraitscomplicatesdeterminationofcausalrelationshipsinan
observationalsetting.
7
MaternalgenotypesmaybeusedinaMendelianrandomization13,14approachtoprovideevidenceof
apotentialcausalassociationbetweenmaternaltraitsandbirthoutcomes(Figure1).Mendelian
randomizationisanalogoustoarandomizedcontrolledtrial:genotypes,whicharerandomly
allocatedatconception,arelargelyfreefromconfoundingandcanbeusedtoestimatethepossible
causaleffectsofmaternaltraits.Inthisstudy,geneticvariantswereselectedtocalculategenetic
scoresrepresentingmaternalBMIandeachof7obesity-relatedmaternaltraits.Thepotentialcausal
relationshipbetweenmaternalBMIandeachrelatedtraitwasestimatedbytestingassociations
betweenmaternalgeneticriskscoresandoffspringbirthweights.
8
Methods
Studyparticipants
Singlenucleotidepolymorphism(SNP)genotypedatawereusedfromatotalof30,487womenfrom
18population-orcommunity-basedstudieslocatedinEurope,NorthAmericaorAustralia.Thebirth
weightofonechildpermotherwasincluded(seeeTable1forfulldetailsofparticipant
characteristicsandeTable2forgenotypinginformation).Birthweightwasmeasuredbytrained
studypersonnel(n=2studies),frommedicalrecords(n=10studies)orfrommaternalreport(n=6
studies).Theoffspringyearsofbirthwerefrom1929to2013.Multiplebirths,stillbirths,congenital
anomalies,birthsbefore37weeksgestationandindividualsofnon-Europeanancestrywere
excluded.Informedconsentwasobtainedfromallparticipants,andstudyprotocolswereapproved
bythelocalregionalorinstitutionalethicscommittees.
Selectionofmaternalobesity-relatedtraitsandSNPs
InadditiontoBMI,traitswereselectedthatareassociatedwithmaternalobesityandmayaffect
fetalgrowththroughtheintrauterineenvironment.Theireffectsweremodelledinthedirections
hypothesisedbytheirrelationshipstomaternalBMI(Box1)
SNPsknowntoberobustlyassociated(P<5x10-8)withBMIandeachobesity-relatedtraitwere
selected.FulldetailsoftheselectedSNPsareprovidedineTable3.SNPsassociatedwith(i)fasting
glucoseand(ii)type2diabeteswereusedtorepresentmaternalglycemia.TheType2diabetesSNPs
wereconsideredtorepresentexposuretomaternaldiabetesinpregnancy,includinggestational
diabetes,givenoverlapbetweentype2andgestationaldiabetesgeneticsusceptibilityvariants.15For
bloodpressure,SNPswereselectedthatareprimarilyassociatedwithsystolicbloodpressure(SBP),
thoughallalsoshowstrongevidenceofassociationwithdiastolicbloodpressure.ForvitaminD
status,twoSNPswithhypothesisedrolesinvitaminDsynthesiswereusedtorepresent25(OH)D
9
levels(anindicatorofoverallvitaminDstatus),aspreviouslyrecommended.16,17Furtherdetailsof
SNPselectionareprovidedintheeMethods.
Aweightedgeneticscorewascalculatedforeachmaternaltrait(seeeMethodsforfulldetails).Very
fewoftheselectedSNPshavebeentestedinpregnancy.Geneticscoreswerevalidatedby
confirmingthateachwasassociatedwithitsrespectivematernaltrait,measuredduringpregnancy
(withtheexceptionofBMI,forwhichthepre-pregnancyvaluewasused).Maternalpre-pregnancy
BMIwasavailablefromregistrydata(N=2studies)orcalculatedfromself-reportedweightand
height(N=3studies).IntheAvonLongitudinalStudyofParentsandChildren(ALSPAC)study,the
self-reportwasvalidatedwithaclinicmeasure18.Detailsoftraitsmeasuredinpregnancyandtheir
sourcesaregivenineTable4.Ineachavailablestudy,linearregressionofthematernaltrait(e.g.
BMI)againstthegeneticscorewasperformed,adjustingformaternalage.Toconfirmthat
associationsbetweeneachgeneticscoreanditsrespectivematernaltraitweresimilarinthesame
individualsduringandafterpregnancy,availabledatawereusedfromtwolongitudinalstudies(the
AvonLongitudinalStudyofParentsandChildren[ALSPAC]andtheExeterFamilyStudyofChildhood
Health[EFSOCH]).TocheckthatthestrategyforSNPselectionhadresultedingeneticscoresthat
werespecifictoeachmaternaltrait,theassociationwastestedbetweeneachofthe8geneticscores
andtheothermaternaltraits,andindicatorsofmaternalsocio-economicstatusandsmoking.
TestingthehypothesisthatmaternalBMIandobesity-relatedtraitsareassociatedwithbirth
weightthroughtheintra-uterineenvironment.
ForBMIandeachrelatedmaternaltrait,twoMendelianrandomizationapproacheswereusedto
testthehypothesis.First,associationsweretestedbetweengeneticscoresrepresentingmaternal
traitsandoffspringbirthweightusingthemaximumnumberofparticipants(i.e.foreachtrait,those
withgeneticscoreandoffspringbirthweightdataavailable,irrespectiveofwhethertheyhadthe
maternaltraitmeasured).Anassociationofthegeneticscorewithbirthweightwouldsupporta
10
possiblecausalrelationshipbetweenthetrait(e.g.pre-pregnancyBMI)andbirthweight,butwould
notprovideinformationonthesizeofthatassociation.Second,weperformedanalysesinthosewith
themeasuredtraitthatenabledanestimateofthesizeofapossiblecausalrelationship.The
analysestookintoaccounttheassociationbetweeneachgeneticscoreandthematernaltraitit
represented(e.g.BMI),inadditiontotheassociationbetweenthesamegeneticscoreandbirth
weight.Thesetworesultswereusedtocalculateanassociationbetweenthematernaltrait(e.g.
BMI)andbirthweightthatwasfreefromconfounding.Thissecondapproachmeasuresthe
relationshipbetweenvariationinmaternalBMI(orBMI-relatedtrait)andbirthweightthatis
attributableonlytogeneticfactors(seeFigure1foranexplanationofthemethod).Foreach
approachmeta-analysiswasusedtocombinedatafromindividualstudies(seeeMethods).
Usingthefirstapproach,weinvestigatedtheassociationbetweeneachgeneticscoreand(i)birth
weightand(ii)ponderalindex(anindexofneonatalleanness,measuredinkg/m3).Withineach
study,birthweightorponderalindexZ-scoreswereregressedagainsteachmaternalgeneticscore,
adjustedforoffspringsexandgestationalage.Analysesusingthetype2diabetesgeneticscorewere
repeatedafterexcludingparticipantswithpre-existingandgestationaldiabetes.Analysesusingthe
SBPgeneticscorewererepeatedafterexcludingparticipantswithpre-eclampsiaandexistingor
gestationalhypertension.
Thegeneticestimateoftheassociationbetweeneachmaternaltraitandbirthweight/ponderal
indexfromthesecondapproachwascomparedwiththecorrespondingobservationalassociation.
Toobtaintheobservationalestimateslinearregressionwasperformedusingbirthweightor
ponderalindexasthedependentvariable,andeachof7maternaltraitsasindependentvariables,
adjustingforsexandgestationalage.Therewasinsufficientinformationonmaternaltype2diabetes
prevalence,soitwasnotpossibletoestimatethecausalrelationshipforthattrait.Fulldetailsofthe
analysisareprovidedintheeMethods.
11
EstimatinghowmuchoftheassociationbetweenmaternalBMIandbirthweightismediatedby
fastingglucose
Availabledatawereusedtoestimatetheapproximatecausalrelationshipbetweena1SD(≈4kg/m2)
highermaternalBMIand(i)fastingglucoseand(ii)SBP.Usingeachofthoseestimates,theresultsof
theMendelianrandomizationanalyseswererescaledtorepresenttheeffectsoffastingglucoseand
SBPthatcouldbedirectlycomparedwiththecausalrelationshipbetweena1SDhigherBMIand
birthweight(seeeMethodsforadetaileddescriptionofthemethod).
Correctingfordirectfetalgenotypeeffects
Genotypesofmaternal-fetalpairswereavailableinupto8studies(N=upto11,494).Analyseswere
repeatedincludingthefetalgenotypeateachSNPinthemodel,tocorrectforpotentialconfounding
causedbydirecteffectsofthefetalgenotype.
12
Results
Thecharacteristicsofincludedparticipantsfromthe18contributingstudiesareshowninTable1.
Amongthe30,487newbornsthemeanbirthweightrangedfrom3325gto3679g.Themeanpre-
pregnancyBMIwasavailablein11studiesandrangedfrom22.78kg/m2to24.83kg/m2.Themean
maternalageatdelivery,availablein16studies,rangedfrom24.5yearsto31.5years.
Therewasevidenceofassociationbetweeneachgeneticscoreanditscorrespondingmaternaltrait
measuredinpregnancy(P≤0.003;Table2).ForBMI,fastingglucoseandSBP,datafrommultiple
studiesweremeta-analysed,withsimilareffectestimatesbetweenstudiesforBMIandfasting
glucose(Phet>0.05)andevidenceofheterogeneityforSBP(Phet=0.04).Theeffectsizesofassociations
betweenmaternaltraitsandtheirrespectivegeneticscoreswereverysimilarwhencomparedinthe
sameindividualsduringandoutsidepregnancy,withtheexceptionoftheSBPgeneticscorewhich
hadaweakereffectduringpregnancy(eTable5).Therewasnoevidenceofassociationbetweenany
geneticscoreandpotentiallyconfoundingvariables.Noindividualgeneticscorewasassociatedwith
anyoftheothermaternaltraits,exceptforthegeneticscoreforBMI,whichwaspositively
associatedwithSBP(P<0.003Bonferroni-correctedfor15tests;eTable6).
GeneticevidenceforapossiblecausalassociationbetweenhighermaternalBMIandhigherbirth
weight
ThematernalBMIgeneticscorewasassociatedwithhigherbirthweight(Table3)andponderal
index(eTable7)withsimilareffectsizesbeforeandafteradjustingforpossibleeffectsoffetal
genotype.Usingthegeneticscoretoquantifythepossiblecausalassociation,a1SDgenetically
highermaternalBMI(equivalentto4kg/m2)wasassociatedwitha55g(95%CI:17,93)higher
offspringbirthweight.Afteradjustingforfetalgenotype,theestimatedeffectwas104g(95%CI:32,
176)(Table4).TheseMendelianrandomizationcausalestimatesweresimilartotheobservational
13
associationof62g(95%CI:56,70)per1SD(4kg/m2)highermaternalBMI(Figure2).Similarresults
wereobtainedforponderalindex(eTable8andeFigure1).
Geneticevidenceforapossiblecausalassociationbetweenhighermaternalfastingglucoseand
higherbirthweight,butnoassociationwithmaternallipidsoradiponectin
Thematernalfastingglucoseandtype2diabetesgeneticscoreswereassociatedwithhigherbirth
weight(Table3)andponderalindex(eTable7)withsimilareffectsizeestimatesbeforeandafter
adjustingforfetalgenotype,andbeforeandafterexcludingpre-existingandgestationaldiabetes.
Usingthegeneticscoretoestimatethepossiblecausalrelationship,a1SD(0.4mmol/L)genetically
highermaternalglucosewasassociatedwitha114g(95%CI:80,147)higherbirthweight.After
adjustingforfetalgenotype,theassociationwas145g(95%CI:91,199)(Table4).Thesegenetic
estimatesweresimilartotheobservationalassociationof92g(95%CI:80,104)per1SD(0.4mmol/L)
highermaternalglucose(Figure2).Similarresultswereobtainedforponderalindex(eTable8and
eFigure1).
Thematernaltriglyceridegeneticscorewasnotassociatedwithoffspringbirthweight(Table3)or
ponderalindex(eTable7).Usingthegeneticscoretoestimatethepossiblecausalrelationship,a
geneticallyhighermaternaltriglyceridelevelwasnotassociatedwithoffspringbirthweightandthe
95%confidenceintervalsaroundthegeneticestimateexcludedtheobservationalassociation
betweenmaternaltriglyceridesandbirthweight(P=0.007testingdifferencebetweengeneticand
observationalassociation;Table4;Figure2).Likewise,thegeneticestimateofthepossibleeffectof
maternaladiponectinlevelsonoffspringbirthweightwasdifferentfromtheobservational
association(P=0.002).ThegeneticscoreforHDLcwasnotassociatedwithbirthweightorponderal
indexandtheanalysiswasconsistentwithnocausalrelationship,howeverthiscouldnotbe
distinguishedfromthenegativeobservationalassociationbetweenmaternalHDLcandbirthweight.
14
Geneticevidenceforapossiblecausalassociationbetweenhighersystolicbloodpressureand
lowerbirthweight
ThematernalSBPgeneticscorewasassociatedwithlowerbirthweight(Table3)andponderalindex
(eTable7)withsimilareffectsizeestimatesbeforeandafteradjustingforfetalgenotype,andbefore
andafterexcludingmaternalpre-eclampsiaandhypertension.Usingthegeneticscoretoestimate
thepossiblecausalrelationship,a1SD(10mmHg)geneticallyhighermaternalSBPwasassociated
witha-208g(95%CI;-394,-21)loweroffspringbirthweight.Afteradjustingforfetalgenotype,the
estimatedeffectwas-151g(95%CI:-390,89)(Table4).Thegeneticestimateoftheassociation
betweenmaternalSBPandbirthweightinthefullsampleofwomenwasintheoppositedirectionto
theobservationalassociation(P=0.01fordifferencebetweengeneticandobservationalassociations;
Table4;Figure2).Similarresultswereobtainedforponderalindex(eTable8andeFigure1).
ThematernalgeneticscoreforlowervitaminDstatuswasassociatedwithlowerbirthweight
(P=0.03;Table3).However,theestimatedcausalrelationshipwasnotsignificantlydifferentfrom
zero(theestimatedchangeinbirthweightfora10%geneticallylowermaternal25[OH]Dlevelwas-
26g(95%CI:-54,2);Table4,Figure2).
Associationsbetweenthegeneticscoresandbirthweightwereconsistentacrossstudies
Associationsbetweenmaternalgeneticscoresandoffspringbirthweightweresimilarbetween
studiesinthemeta-analysis(Table3;Phet>0.05).Wheredatawerecombinedfromobservational
analyses,theassociationsbetweenmaternalfastingglucoseorSBPandbirthweightweresimilar
(Phet>0.05),andtherewasevidenceofheterogeneityfortheBMI-birthweightobservational
association(Table4;Phet=0.03).
Exposureofthefetustohighermaternalfastingglucoseisunlikelytoexplainalloftheassociation
betweenhighermaternalBMIandhigheroffspringbirthweight
15
ToestimatehowmuchoftheassociationbetweenmaternalBMIandbirthweightmightbe
mediatedbyfastingglucose,theBMIandfastingglucosegeneticscoreswereused:a1SD(≈4
kg/m2)geneticallyhighermaternalBMIwasassociatedwitha0.34SD(≈0.14mmol/L)higher
maternalfastingglucose.FromtheMendelianrandomizationanalyses,1SD(≈0.4mmol/L)
geneticallyhighermaternalfastingglucosewasassociatedwitha114g(95%CI:80,147)higherbirth
weight.Consequently,itwaspredictedthata0.34SDhigherfastingglucosewouldbeassociated
witha114g×0.34=39g[95%CI:27,50]higherbirthweight.Thisapproximationisbroadlysimilarto
thetotalestimatedeffectofa1SDhigherBMIonbirthweight(55g[95%CI:17,93]).However,using
thesamemethodwiththeBMIandSBPgeneticscoresweestimatedthata1SDhighermaternalBMI
wouldbeassociatedwitha-40g[95%CI:-75,-4]lowerbirthweightviaitsassociationwithmaternal
SBP(eFigure2),whichwouldopposethepositiveassociationwithmaternalfastingglucose.
16
Discussion
ThisstudyprovidesevidenceforapossiblecausalassociationbetweenmaternalBMIandoffspring
birthweight.A4kg/m2geneticallyhighermaternalBMI(a1SDrise)wasassociatedwitha55g(95%
CI:17,93)higheroffspringbirthweight.Inaddition,a0.4mmol/l(1SD)geneticallyhighercirculating
maternalfastingglucosewasassociatedwitha114g(95%CI:80,147)higherbirthweight,whilea10
mmHggeneticallyhighermaternalSBPwasassociatedwitha-208g(95%CI:-394,-21)lowerbirth
weight.TheseresultsprovideevidencethatgeneticallyelevatedmaternalglucoseandSBPhave
directionallyoppositecausalassociationswithbirthweight.Theestimatedassociationsbetween
thesematernaltraitsandbirthweight(eitherincreasedorreduced)aresubstantialandofclinical
importance.Theysupporteffortstomaintainhealthygestationalglucoseandbloodpressurelevels
toensurehealthyfetalgrowth.ThepositiveassociationbetweenmaternalBMIandbirthweight
maybepartiallymediatedbytheeffectofhigherBMIoncirculatingmaternalfastingglucose.There
wasnoevidenceofassociationwithageneticscoreformaternaltriglycerides,whichhavealsobeen
hypothesisedtobeimportantcontributorstohigherbirthweightinoverweightorobesewomen.
Otherlipids,orspecificsubclassesoftriglycerides,mightbeimportantbutrequirefurtherstudy.
Theseresultsprovidegeneticevidenceofacausalassociationbetweenmaternalglycemiaandbirth
weightandponderalindex,eveninwomenwithnopre-existingorgestationaldiabetes,whichis
consistentwithpublishedobservationaldata.5Apossibleexplanationforthisfindingisthatwomen
withahighergeneticscorefortype2diabeteshaverelativelyhigherglucoselevelsinpregnancy,as
aresultofinadequatebetacellcompensationinresponsetogestationalinsulinresistance,19,20
leadingtoincreasedplacentalglucosetransferandfetalinsulinsecretion,21andconsequentlyhigher
birthweight.
Thesedatadidnotsupportacausalassociationbetweenmaternaltriglyceride,HDLcoradiponectin
levelsandbirthweightorponderalindex.Thegeneticassociationsbetweenmaternaltriglycerides
17
andadiponectinandbirthweightwerenull,incontrasttotheobservationalassociations,suggesting
thattheobservationalassociationsseenhere,andinotherpublishedstudies8,9,12,areconfounded.
TheMendelianrandomizationanalysisshowedthatthepositiveobservationalassociationbetween
SBPandbirthweightisconfounded,mostlikelybyBMI,whichisbothanimportantriskfactorfor
higherSBPinpregnancyandpositivelyassociatedwithbirthweight.1Usinggeneticvariantsthatare
independentofconfoundingbyBMI,itwasdemonstratedthatgeneticallyhighermaternalSBPis
associatedwithlowerbirthweight,evenafterexcludingpre-eclampsiaandhypertension.The
precisionofourestimateofthechangeinbirthweightper1SDinmaternalSBPcouldbeaffectedby
theheterogeneitybetweenstudiesinthegeneticscore-SBPassociation(P=0.04,I2=76.0%;Table2).
However,associationsbetweentheSBPgeneticscoreandbirthweightwereconsistentacrossall13
meta-analyzedstudies(P=0.14,I2=30.4%;Table3)andsupportiveofacausalassociationbetween
highermaternalSBPandlowerbirthweight.Thesefindingssupportobservationalassociations
betweenmaternalSBPandbirthweightthatwereadjustedforawiderangeofconfounders,22and
areconsistentwithlaboratoryandpopulationstudiessuggestingalinkbetweenhypertensive
disordersofpregnancyandimpairedfetalgrowthduetoplacentalpathology.23Thereareincreasing
concernsabouttheeffecttheobesityepidemicmighthaveonbirthsize,viagreatermaternalBMI.
However,thefocusofthatconcernhasbeenlargelyonincreasedbirthsizeasaresultofgreater
maternalglucoseandotherfetalnutrients.Ourfindingssuggestthatthereareopposingeffectsof
maternalbloodpressureandglucose.
PublishedMendelianrandomizationanalysesprovideevidencethathigherBMIiscausallyassociated
withlowervitaminDstatus,6andevidencefrommultipleobservationalstudiessuggeststhatlower
maternalvitaminDisassociatedwithlowerbirthweight.11,24OuranalysisofthevitaminDgenetic
scoreprovidedsomeevidencetosupportapossiblecausalassociationwithbirthweight,butthis
requiresfurtherexplorationinlargernumbersofpregnancies.
18
Socio-economicfactorsandrelatedbehaviourssuchassmokingarekeyconfoundersof
observationalassociationsbetweenmaternalBMI(orBMI-relatedtraits)andoffspringbirthweight,
sincetheyareassociatedwithbothvariables(seeeTable9forademonstrationoftheseassociations
intheALSPACstudy).Thegeneticscoresusedinouranalyseswerenotassociatedwithsocio-
economicfactorsorsmoking,andthisillustratesakeystrengthoftheMendelianrandomization
approach:sincegenotypesaredeterminedatconception,suchconfoundingisavoided.
Therearesomelimitationstothisstudy.Despiteattemptstomaximisespecificityofthegenetic
scores,wecannotfullyexcludethepossibilitythattheselectedgeneticvariantsactonmorethan
onematernaltrait.Althoughallavailableinformationwasused,therewaslimitedpowertodetect
associationsbetweenthegeneticscoresandothertraits.Forexample,theknownassociation
betweenBMI-associatedvariantsandtriglyceridelevelswasnotdetected.25Withthepotentialfor
high-throughputmetabolomicstudiesandagrowingpublicdatabaseofgeneticassociations,26-28
futurestudieswillimprovethespecificity(fordifferentlipidsub-fractions)ofselectedgenetic
variants.
Despitethelargesampleinthisstudy,statisticalpowertodetectcausalrelationshipswaslimitedfor
somematernaltraits(seeeMethodsandeTable10forpowercalculations).Thetotalsample
provided>99%powertodetectassociationsatP<0.05betweenbirthweightandgeneticscoressuch
asfastingglucoseandsystolicbloodpressurethatexplainatleast0.1%varianceinbirthweight.
However,largersamples(N>80,000)willbeneededtoconfidentlydetectorruleout(i)the
associationwithvitaminDstatussuggestedbyourdata,or(ii)smallerpositiveornegativecausal
associationsbetweenmaternaltriglycerides,HDLcoradiponectinandbirthweight.
19
Whileadjustingforthefetalgeneticscoreswasnecessarytoseparatematernaleffectsfromthe
directeffectsofgeneticvariantsinthefetus,thiscouldpotentiallyintroducebiasviaassociation
withpaternalgenotypes.AssortativematingforBMIcouldadditionallyresultinacorrelation
betweenmaternalandpaternalgenotypes,leadingtosimilarbias.However,afather’sgeneticscore
wouldonlyconfoundtheMendelianrandomizationestimatesifthefather’sphenotypewererelated
tobirthweight,andwefoundonlyveryweakassociationsoffathersBMIandrelatedtraitswith
offspringbirthweight(eTable11).Anotherpotentialbiascouldbeinducedbytheuseofthegenetic
scoreforSBP,whichwasderivedfromagenome-wideassociationstudyofbloodpressure
conditionalonBMI.SinceBMIisalsoassociatedwithbirthweight,thiscouldbiastheresults.
However,similarresultswereobtainedusinganalternativegeneticscorethatwasunadjustedfor
BMI(eMethods).
InMendelianrandomizationanalysis,aweakstatisticalassociationbetweenageneticscoreanda
maternaltrait(duetolowvarianceexplainedand/orsmallsamplesize)hasthepotentialtocause
weakinstrumentbiastowardstheobservationalresults.29Theproportionsofmaternaltraitvariance
explainedbythegeneticscoresaremodestinourstudy(Table2).However,thelargeoverallsample
sizeensuredthatthepossiblecausalassociationsidentifiedareunlikelytobeduetoweak
instrumentbias(seeeMethods).
OuranalysesassumethatmaternalBMIandrelatedtraitsarelinearlyassociatedwithoffspringbirth
weight.Wehavenottestedfornon-linearassociationswhich,inaMendelianrandomizationdesign,
wouldrequireverylargenumbers30.However,formaternalBMI,fastingglucoseandsystolicblood
pressure,thereisobservationalevidenceofsuchlinearassociationsacrossthedistribution,withno
evidenceofthresholdorcurvilinearassociations5,10,31.
20
Conclusions
InthisMendelianrandomizationstudyofmorethan30,000womenwithsingletonoffspringfrom18
studies,geneticallyelevatedmaternalBMIandbloodglucoselevelswerepotentiallycausally
associatedwithhigheroffspringbirthweight,whereasgeneticallyelevatedmaternalsystolicblood
pressurewasshowntobepotentiallycausallyrelatedtolowerbirthweight.Ifreplicated,these
findingsmayhaveimplicationsforcounselingandmanagingpregnanciestoavoidadverseweight-
relatedbirthoutcomes.
21
REFERENCES
1. LawlorDA,ReltonC,SattarN,NelsonSM.Maternaladiposity--adeterminantofperinatalandoffspringoutcomes?NatRevEndocrinol.2012;8(11):679-688.
2. ShinD,SongWO.Prepregnancybodymassindexisanindependentriskfactorforgestationalhypertension,gestationaldiabetes,pretermlabor,andsmall-andlarge-for-gestational-ageinfants.JMaternFetalNeonatalMed.2014:1-8.
3. HarmonKA,GerardL,JensenDR,etal.Continuousglucoseprofilesinobeseandnormal-weightpregnantwomenonacontrolleddiet:metabolicdeterminantsoffetalgrowth.DiabetesCare.2011;34(10):2198-2204.
4. LandonMB,MeleL,SpongCY,etal.Therelationshipbetweenmaternalglycemiaandperinataloutcome.ObstetGynecol.2011;117(2Pt1):218-224.
5. MetzgerBE,LoweLP,DyerAR,etal.Hyperglycemiaandadversepregnancyoutcomes.NEnglJMed.2008;358(19):1991-2002.
6. VimaleswaranKS,BerryDJ,LuC,etal.CausalrelationshipbetweenobesityandvitaminDstatus:bi-directionalMendelianrandomizationanalysisofmultiplecohorts.PLoSMed.2013;10(2):e1001383.
7. GaillardR,DurmusB,HofmanA,MackenbachJP,SteegersEA,JaddoeVW.Riskfactorsandoutcomesofmaternalobesityandexcessiveweightgainduringpregnancy.Obesity(SilverSpring).2013;21(5):1046-1055.
8. MisraVK,TrudeauS,PerniU.Maternalserumlipidsduringpregnancyandinfantbirthweight:theinfluenceofprepregnancyBMI.Obesity(SilverSpring).2011;19(7):1476-1481.
9. KulkarniSR,KumaranK,RaoSR,etal.Maternallipidsareasimportantasglucoseforfetalgrowth:findingsfromthePuneMaternalNutritionStudy.DiabetesCare.2013;36(9):2706-2713.
10. Macdonald-WallisC,TillingK,FraserA,NelsonSM,LawlorDA.Associationsofbloodpressurechangeinpregnancywithfetalgrowthandgestationalageatdelivery:findingsfromaprospectivecohort.Hypertension.2014;64(1):36-44.
11. LeffelaarER,VrijkotteTG,vanEijsdenM.MaternalearlypregnancyvitaminDstatusinrelationtofetalandneonatalgrowth:resultsofthemulti-ethnicAmsterdamBornChildrenandtheirDevelopmentcohort.BrJNutr.2010;104(1):108-117.
12. LoweLP,MetzgerBE,LoweWL,Jr.,etal.Inflammatorymediatorsandglucoseinpregnancy:resultsfromasubsetoftheHyperglycemiaandAdversePregnancyOutcome(HAPO)Study.JClinEndocrinolMetab.2010;95(12):5427-5434.
13. DaveySmithG,EbrahimS.'Mendelianrandomization':cangeneticepidemiologycontributetounderstandingenvironmentaldeterminantsofdisease?IntJEpidemiol.2003;32(1):1-22.
14. LawlorDA,HarbordRM,SterneJA,TimpsonN,DaveySmithG.Mendelianrandomization:usinggenesasinstrumentsformakingcausalinferencesinepidemiology.StatMed.2008;27(8):1133-1163.
15. KwakSH,KimSH,ChoYM,etal.Agenome-wideassociationstudyofgestationaldiabetesmellitusinKoreanwomen.Diabetes.2012;61(2):531-541.
16. BerryDJ,VimaleswaranKS,WhittakerJC,HingoraniAD,HypponenE.EvaluationofgeneticmarkersasinstrumentsforMendelianrandomizationstudiesonvitaminD.PLoSOne.2012;7(5):e37465.
17. VimaleswaranKS,CavadinoA,BerryDJ,etal.AssociationofvitaminDstatuswitharterialbloodpressureandhypertensionrisk:amendelianrandomisationstudy.LancetDiabetesEndocrinol.2014;2(9):719-729.
18. LawlorDA,FraserA,LindsayRS,etal.Associationofexistingdiabetes,gestationaldiabetesandglycosuriainpregnancywithmacrosomiaandoffspringbodymassindex,waistandfatmassinlaterchildhood:findingsfromaprospectivepregnancycohort.Diabetologia.2010;53(1):89-97.
22
19. HayesMG,UrbanekM,HivertMF,etal.IdentificationofHKDC1andBACE2asgenesinfluencingglycemictraitsduringpregnancythroughgenome-wideassociationstudies.Diabetes.2013;62(9):3282-3291.
20. FreathyRM,HayesMG,UrbanekM,etal.HyperglycemiaandAdversePregnancyOutcome(HAPO)study:commongeneticvariantsinGCKandTCF7L2areassociatedwithfastingandpostchallengeglucoselevelsinpregnancyandwiththenewconsensusdefinitionofgestationaldiabetesmellitusfromtheInternationalAssociationofDiabetesandPregnancyStudyGroups.Diabetes.2010;59(10):2682-2689.
21. PedersenJ.Thepregnantdiabeticandhernewborn:problemsandmanagement.Baltimore:Williams&Wilkins;1977.
22. LawlorDA,DaveySmithG,EbrahimS.Birthweightofoffspringandinsulinresistanceinlateadulthood:crosssectionalsurvey.BMJ.2002;325(7360):359.
23. Rich-EdwardsJW,FraserA,LawlorDA,CatovJM.Pregnancycharacteristicsandwomen'sfuturecardiovascularhealth:anunderusedopportunitytoimprovewomen'shealth?EpidemiolRev.2014;36(1):57-70.
24. BodnarLM,CatovJM,ZmudaJM,etal.Maternalserum25-hydroxyvitaminDconcentrationsareassociatedwithsmall-for-gestationalagebirthsinwhitewomen.JNutr.2010;140(5):999-1006.
25. FallT,HaggS,MagiR,etal.Theroleofadiposityincardiometabolictraits:aMendelianrandomizationanalysis.PLoSMed.2013;10(6):e1001474.
26. WurtzP,WangQ,KangasAJ,etal.Metabolicsignaturesofadiposityinyoungadults:mendelianrandomizationanalysisandeffectsofweightchange.PLoSMed.2014;11(12):e1001765.
27. ShinSY,FaumanEB,PetersenAK,etal.Anatlasofgeneticinfluencesonhumanbloodmetabolites.NatGenet.2014;46(6):543-550.
28. KettunenJ,TukiainenT,SarinAP,etal.Genome-wideassociationstudyidentifiesmultiplelociinfluencinghumanserummetabolitelevels.NatGenet.2012;44(3):269-276.
29. BurgessS,ThompsonSG,CollaborationCCG.AvoidingbiasfromweakinstrumentsinMendelianrandomizationstudies.IntJEpidemiol.2011;40(3):755-764.
30. SilverwoodRJ,HolmesMV,DaleCE,etal.Testingfornon-linearcausaleffectsusingabinarygenotypeinaMendelianrandomizationstudy:applicationtoalcoholandcardiovasculartraits.IntJEpidemiol.2014;43(6):1781-1790.
31. GroupHSCR.HyperglycaemiaandAdversePregnancyOutcome(HAPO)Study:associationswithmaternalbodymassindex.BJOG.2010;117(5):575-584.
32. CatalanoPM,McIntyreHD,CruickshankJK,etal.Thehyperglycemiaandadversepregnancyoutcomestudy:associationsofGDMandobesitywithpregnancyoutcomes.DiabetesCare.2012;35(4):780-786.
33. FraserA,Macdonald-WallisC,TillingK,etal.CohortProfile:theAvonLongitudinalStudyofParentsandChildren:ALSPACmotherscohort.IntJEpidemiol.2013;42(1):97-110.
34. SchlemmL,HaumannHM,ZiegnerM,etal.Newevidenceforthefetalinsulinhypothesis:fetalangiotensinogenM235Tpolymorphismisassociatedwithbirthweightandelevatedfetaltotalglycatedhemoglobinatbirth.JHypertens.2010;28(4):732-739.
35. PowerC,ElliottJ.Cohortprofile:1958Britishbirthcohort(NationalChildDevelopmentStudy).IntJEpidemiol.2006;35(1):34-41.
36. ZhaoJ,LiM,BradfieldJP,etal.Examinationoftype2diabeteslociimplicatesCDKAL1asabirthweightgene.Diabetes.2009;58(10):2414-2418.
37. BisgaardH.TheCopenhagenProspectiveStudyonAsthmainChildhood(COPSAC):design,rationale,andbaselinedatafromalongitudinalbirthcohortstudy.AnnAllergyAsthmaImmunol.2004;93(4):381-389.
23
38. NohrEA,TimpsonNJ,AndersenCS,DaveySmithG,OlsenJ,SorensenTI.Severeobesityinyoungwomenandreproductivehealth:theDanishNationalBirthCohort.PLoSOne.2009;4(12):e8444.
39. OlsenJ,MelbyeM,OlsenSF,etal.TheDanishNationalBirthCohort--itsbackground,structureandaim.ScandJPublicHealth.2001;29(4):300-307.
40. KnightB,ShieldsBM,HattersleyAT.TheExeterFamilyStudyofChildhoodHealth(EFSOCH):studyprotocolandmethodology.PaediatrPerinatEpidemiol.2006;20(2):172-179.
41. LacroixM,BattistaMC,DoyonM,etal.Loweradiponectinlevelsatfirsttrimesterofpregnancyareassociatedwithincreasedinsulinresistanceandhigherriskofdevelopinggestationaldiabetesmellitus.DiabetesCare.2013;36(6):1577-1583.
42. JaddoeVW,vanDuijnCM,FrancoOH,etal.TheGenerationRStudy:designandcohortupdate2012.EurJEpidemiol.2012;27(9):739-756.
43. MagnusP,IrgensLM,HaugK,etal.Cohortprofile:theNorwegianMotherandChildCohortStudy(MoBa).IntJEpidemiol.2006;35(5):1146-1150.
44. RantakallioP.Groupsatriskinlowbirthweightinfantsandperinatalmortality.ActaPaediatrScand.1969;193:Suppl193:191+.
45. BoomsmaDI,deGeusEJ,VinkJM,etal.NetherlandsTwinRegister:fromtwinstotwinfamilies.TwinResHumGenet.2006;9(6):849-857.
46. MedlandSE,NyholtDR,PainterJN,etal.CommonvariantsinthetrichohyalingeneareassociatedwithstraighthairinEuropeans.AmJHumGenet.2009;85(5):750-755.
47. MoayyeriA,HammondCJ,ValdesAM,SpectorTD.CohortProfile:TwinsUKandhealthyageingtwinstudy.IntJEpidemiol.2013;42(1):76-85.
48. MoayyeriA,HammondCJ,HartDJ,SpectorTD.TheUKAdultTwinRegistry(TwinsUKResource).TwinResHumGenet.2013;16(1):144-149.
49. SpeliotesEK,WillerCJ,BerndtSI,etal.Associationanalysesof249,796individualsreveal18newlociassociatedwithbodymassindex.NatGenet.2010;42(11):937-948.
50. DupuisJ,LangenbergC,ProkopenkoI,etal.Newgeneticlociimplicatedinfastingglucosehomeostasisandtheirimpactontype2diabetesrisk.Nat.Genet.2010;42(2):105-116.
51. MorrisAP,VoightBF,TeslovichTM,etal.Large-scaleassociationanalysisprovidesinsightsintothegeneticarchitectureandpathophysiologyoftype2diabetes.NatGenet.2012;44(9):981-990.
52. TeslovichTM,MusunuruK,SmithAV,etal.Biological,clinicalandpopulationrelevanceof95lociforbloodlipids.Nature.2010;466(7307):707-713.
53. EhretGB.Genome-wideassociationstudies:contributionofgenomicstounderstandingbloodpressureandessentialhypertension.CurrHypertensRep.2010;12(1):17-25.
54. YaghootkarH,LaminaC,ScottRA,etal.Mendelianrandomizationstudiesdonotsupportacausalroleforreducedcirculatingadiponectinlevelsininsulinresistanceandtype2diabetes.Diabetes.2013;62(10):3589-3598.
55. FreathyRM,Mook-KanamoriDO,SovioU,etal.VariantsinADCY5andnearCCNL1areassociatedwithfetalgrowthandbirthweight.Nat.Genet.2010;42(5):430-435.
24
ARTICLEINFORMATION
AuthorContributionsDr.FreathyandProfsLawlorandFraylinghadfullaccesstoallofthedataintheALSPAC,EFSOCHandHAPO(non-GWAS)studiesandaccesstosummarydatafromallcontributingstudiesandtakeresponsibilityfortheintegrityofthedataandaccuracyofthedataanalysis.Studyconceptanddesign:J.Tyrrell,D.A.Lawlor,T.M.Frayling&R.M.FreathyAnalysisandinterpretationofdata:J.Tyrrell,R.C.Richmond,S.Metrustry,B.Feenstra,A.Cavadino,E.Hyppönen,M-FHivert,J.F.Felix,W.L.Lowe,D.A.Lawlor,T.M.Frayling&R.M.FreathyDraftingmanuscript:J.Tyrrell,R.C.Richmond,S.Metrustry,B.Feenstra,A.Cavadino,E.Hyppönen,M-FHivert,J.F.Felix,W.L.Lowe,D.A.Lawlor,T.M.Frayling&R.M.Freathy
Criticalrevisionofmanuscriptforimportantintellectualcontent:Allauthors
Statisticalanalysis:N.M.G.DeSilva,A.R.Wood,G.McMahon,D.M.Evans,E.Kreiner-Møller,F.Geller,C.Allard,J-J.Hottenga,J.P.Bradfield,M.G.Hayes,D.M.Scholtens,L.L.Armstrong,J.Rangaraja,M.Horikoshi,M.I.McCarthy,M.Nodzenski,L.Paternoster,S.Das,V.Huikari,J.N.Painter,S.E.Medland,P.A.Lind,D.J.Berry,R.Myhre,V.Sengpiel,J.Tyrrell,R.C.Richmond,S.Metrustry,B.Feenstra,A.Cavadino,J.F.Felix,D.A.Lawlor&R.M.Freathy
Genotyping:D.M.Evans,S.M.Ring,J.C.Murray,L.Bouchard,J.F.Felix,J-J.Hottenga,H.Hakonarson,T.I.A.Sørensen,N.G.Martin,E.A.Nohr,T.D.Spector,S.F.Grant,D.A.Lawlor,T.M.Frayling&R.M.Freathy
Individualstudydesign:T.D.Spector,B.Jacobsson,C.Power,N.G.Martin,S.Serbert,T.I.A.Sørensen,M.Järvelin,B.Hocher,M.G.Hayes,W.L.Lowe,S.F.Grant,H.Hakonarson,J.P.Bradfield,E.J.C.deGeus,V.W.Jaddoe,A.Hofman,M.Melbye,J.C.Murray,H.Bisgaard,G.DaveySmith,A.T.Hattersley,E.Hyppönen,M-FHivert,J.F.Felix,W.L.Lowe,D.A.Lawlor,&T.M.Frayling
Phenotypingincontributingstudies:T.D.Spector,B.Jacobsson,C.Power,E.Hyppönen,N.G.Martin,T.I.A.Sørensen,E.A.Nohr,C.Reichetzeder,B.Hocher,S.F.Grant,H.Hakonarson,J.P.Bradfield,G.Willemsen,V.W.Jaddoe,M-FHivert,M.Melbye,F.Geller,B.Feenstra,E.Kreiner-Møller,H.Bisgaard,G.DaveySmith,S.M.Ring,D.A.Lawlor,B.Knight,A.T.Hattersley
25
ConflictsofInterestandFinancialDisclosuresNoconflictsofinterestwerereported.Funding/SupportFunding/supportofauthorsisasfollows(fundingdetailsforindividualstudiesarereportedintheSupplementaryMaterial).T.M.FandA.R.WaresupportedbytheEuropeanResearchCouncilgrant:323195SZ-24550371-GLUCOSEGENES-FP7-IDEAS-ERC;A.T.H.andM.I.M.areWellcomeTrustSeniorInvestigators;M.I.M.isanNIHRSeniorInvestigator.R.M.F.isaSirHenryDaleFellow(WellcomeTrustandRoyalSocietygrant:104150/Z/14/Z);J.T.isfundedbytheERDFandaDiabetesResearchandWellnessFoundationFellowship;RCRisfundedbytheWellcomeTrust4-yearstudentship(GrantCode:WT083431MF).D.A.L.,G.D-S.,D.M.E.andS.R.allworkinaUnitthatreceivesfundingfromtheUniversityofBristolandtheUKMedicalResearchCouncil(MC_UU_1201/1/5,MC_UU_1201/1andMC_UU_1201/4).D.A.L.issupportedbyawardsfromtheWellcomeTrust(WT094529MAandWT088806),USNationalInstituteofHealth(R01DK10324)andisanNIHRSeniorInvestigator(NF-SI-0611-10196).D.M.EandS.E.M.weresupportedbyAustralianResearchCouncilFutureFellowship(FT130101709andFT110100548).B.FissupportedbyanOakFoundationScholarship.L.B.isajuniorresearchscholarfromtheFondsdelarechercheensantéduQuébec(FRQS)andamemberoftheFRQS-fundedCentrederechercheduCHUS.M.F.H.isaFRQSresearchscholarsandwasawardedaClinicalScientistAwardbytheCanadianDiabetesAssociationandtheMaudMentenAwardfromtheInstituteofGenetics–CanadianInstituteofHealthResearch(CIHR).C.A.wasawardedtheCIHR-FrederickBantingandCharlesBestCanadaGraduateScholarships.V.W.J.issupportedbytheNetherlandsOrganizationforHealthResearchandDevelopment(ZonMw–VIDI016.136.361).A.P.M.isaWellcomeTrustSeniorResearchFellow(grantnumberWT098017).T.S.isholderofanERCAdvancedPrincipalInvestigatoraward.RoleoftheSponsorsThefundingagencieshadnoroleinthedesignandconductofthestudy;collection,management,analysisandinterpretationofdata;preparation,review,approvalofmanuscript;ordecisiontosubmitmanuscriptforpublication.PreviousPresentationsThisworkwaspresentedattheDiabetesUKAnnualProfessionalConference2014,5-7March,Liverpool,UK.AdditionalContributionsWeareextremelygratefultotheparticipantsandfamilieswhocontributedtoallofthestudiesandtheteamsofinvestigatorsinvolvedineachone.Theseincludeinterviewers,computerandlaboratorytechnicians,clericalworkers,researchscientists,volunteers,managers,receptionistsandnurses.Foradditionalstudy-specificacknowledgements,pleaseseeSupplementaryMaterial.ThisresearchhasbeenconductedusingtheUKBiobankresource.
26
FIGURE/BOXLEGENDS
Box1.Thematernalobesity-relatedtraitshypothesizedtocauseincreasedordecreasedfetalgrowth,
based on observational associations with birth weight: body mass index (BMI)1; fasting glucose5;
gestationalortype2diabetes32;triglycerides9;HDL-cholesterol8;systolicbloodpressure10;vitaminD
status(asindicatedby25-hydroxyvitaminD,25[OH]Dlevel)11;adiponectin12.
Figure1
PrincipleofMendelianrandomization:Ifamaternaltraitcausallyinfluencesoffspringbirthweight,
thenariskscoreofgeneticvariantsassociatedwiththattraitwillalsobeassociatedwithbirth
weight.Sincegenotypeisdeterminedatconception,itshouldnotbeassociatedwithfactorsthat
normallyconfoundtheassociationbetweenmaternaltraitsandbirthweight(e.g.socio-economic
status).Estimatesofthegeneticscore-maternalphenotypeassociation(w)andthegeneticscore-
birthweightassociation(x)maybeusedtoestimatetheassociationbetweenthematernaltrait
variationthatisduetogeneticscore,andbirthweight(y=x/w),whichisexpectedtobefreefrom
confounding.Iftheestimatedcausalrelationship,y,isdifferentfromtheobservationalassociation
betweenthemeasuredmaternalphenotypeandbirthweight,thiswouldsuggestthatthe
observationalassociationisconfounded(assumingthattheassumptionsoftheMendelian
randomizationanalysesarevalid).14Thedashedlineconnectingmaternaltraitwithfetalgrowthhas
noarrow,toindicatethatthecausalnatureoftheassociationisuncertain.Itisimportanttoadjust
forpossibledirecteffectsoffetalgenotype(z).
Figure2.Comparisonoftheobservationalwiththegeneticchangeinbirthweight(ingrams)fora1
standarddeviation(SD)changeineachmaternalobesity-relatedtrait.For25[OH]Dandadiponectin,
wepresentthechangeinbirthweightfora10%changeinmaternaltraitlevelbecausethese
variableswereloggedforanalysis.ThegeneticchangewasestimatedfromMendelian
randomizationanalysis,inwhichageneticscorewasusedtoestimatethepossiblecausal
27
relationshipbetweenthematernaltraitandbirthweight.Thegeneticestimateispresentedtwice:in
thesecondcaseitwasadjustedforfetalgenotypeusingasubsetofavailablestudies.Theerrorbars
representthe95%confidenceintervalsaroundtheeffectsizeestimates.Formaternalpre-
pregnancyBMIandfastingglucose,the95%confidenceintervalsforboththeobservationaland
geneticapproachesexcludethenull,suggestingpositivepossiblecausalrelationshipsbetween
maternalBMIandfastingglucoseandbirthweight.FormaternalSBP,theobservationalanalysis
suggestedaweakpositiveassociationwithbirthweight,whereasthegeneticanalysisshowed
evidenceofanegativepossiblecausalrelationship.Observationalanalysessuggestedthathigher
maternaltriglyceridelevels,lowermaternaladiponectinandlowermaternalHDL-cholesterollevels
wereassociatedwithhigherbirthweight,whilelowermaternalvitaminDstatuswasassociatedwith
lowerbirthweight,butnoneoftheseweresupportedbythegeneticanalyses.
28Table1.Keycharacteristicsofparticipantsbystudy(forfulldetails,seeeTable1)
Abbreviatedstudyname*
Country(samplesource)
Offspringyearsofbirth
Nwomenwithbirthweightofonechild
Noffspringwith
genotype
Meanmaternalageat
deliveryinyears(SD)
Meanmaternal
pre-pregnancyBMI(SD)in
kg/m2
Meanoffspring
birthweight(SD)ingrams
ALSPACmothers33 UK 1991-1992 7304 4913 28.5(4.8) 22.93(3.73) 3481(475)
BBCmothers34 Germany 2000-2004 1357 1357 30.1(5.4) 22.78(3.93) 3472(511)
B58C-WTCCC35 UK 1972-2000 855 NA 26.2(5.2) NA 3325(483)
B58C-T1DGC35 UK 1972-2000 836 NA 26.1(5.4) NA 3379(469)
CHOPmothers36 USA 1987-
present 312 NA NA NA 3440(562)
COPSAC-2000mothers37 Denmark 1998-2001 282 282 30.4(4.3) NA 3560(505)
DNBC-GOYA38 Denmark 1996-2002 1805 NA 29.2(4.2) 23.57(4.27) 3643(495)
DNBC-PTB-CONTROL39 Denmark 1987-2009 1649 975 29.9(4.2) 23.57(4.27) 3595(497)
EFSOCHmothers40 UK 2000-2004 746 332‡ 30.5(5.3) 24.07(4.42) 3512(480)
GEN-3Gmothers41 Canada 2010-2013 676 NA 28.4(4.4) 24.83(5.63) 3448(433)
GenerationRmothers42 TheNetherlands 2002-2006 3810 2196 31.2(4.5)† 23.12(3.92) 3528(494)
HAPOmothers(GWAS)5
UK,Canada,Australia 2000-2006 1380 1300 31.5(5.3)† 24.5(5.0) 3557(517)
HAPOmothers(non-
GWAS)5
USA,UK,Canada,Australia
2000-2006 3590 2318 30.4(5.4)† 24.63(5.33) 3526(463)
MoBamothers43 Norway 1999-2008 650 350 28.5(3.3) 23.93(3.94) 3679(430)
NFBC196644 Finland 1987-2001 2035 NA 26.5(3.7) NA 3525(461)
NTR45 TheNetherlands 1946-2003 706 NA 27.1(3.7) NA 3469(529)
QIMR46 Australia 1929-1990 892 NA Q24.5(4.0)R 22.79(5.13) 3344(532)
TwinsUK47,48 UK NA 1602 NA NA NA 3365(581)
*Expandedstudynames:ALSPAC,AvonLongitudinalStudyofParentsandChildren;BBC,BerlinBirthCohort;B58C-WTCCC,1958BritishBirthCohort-WellcomeTrustCaseControlConsortium;B58C-T1DGC,1958BritishBirthCohort-Type1DiabetesGeneticsConsortium;CHOP,Children’sHospitalOfPhiladelphia;DNBC-GOYA,DanishNationalBirthCohort-GeneticsofObesityinYoungAdultsstudy;DNBC-PTB-CONTROLS,DanishNationalBirthCohortPretermBirthstudyControls;EFSOCH,ExeterFamilyStudyOfChildhoodHealth;GEN-3G,GeneticsofGlycemicregulationinGestationandGrowth;HAPO,HyperglycemiaandAdversePregnancyOutcomestudy(GWAS,Genome-WideAssociationStudy);MoBa,theNorwegianMotherandBabyCohort;NFBC1966,theNorthernFinland1966BirthCohort;NTR,NetherlandsTwinRegistry;QIMR,QueenslandInstituteofMedicalResearch.†InGenerationR,maternalagewasrecorded,onaverage,at14.4weeksofgestation;inHAPO,maternalagewasrecorded,onaverage,at28weeksofgestation.‡FetalgenotypeinEFSOCHavailableonlyforthefastingglucosegeneticscore.NA,notavailable.
29Table2.Associationsbetweenmaternalgeneticscoresandmaternalobesity-relatedtraits
Maternalobesity-relatedtrait
NumberofSNPsusedtoconstructgeneticscore
ReferenceforprimaryGWAS
paperforeachsetofSNPs*
Estimateof%variancein
maternaltraitexplainedby
geneticscoreinpregnantwomen†
TotalNwomenwithtraitmeasured
duringpregnancy(exceptBMI,for
whichtheappropriate
measurementispre-pregnancy)
Nstudies
Estimatedchangeinmaternaltraitperaverageweighted
trait-raising/lowering‡allele(95%CI)
Pvalue
HeterogeneityPvalue;I2%,
whereresultsfrom>1studyweremeta-analysed
Higherpre-pregnancyBodyMassIndex
(BMI)30
Speliotesetal.,2010,NatGenet49
1.8%inALSPAC11,822 5 0.145(0.126,0.164)
kg/m2 <2x10-16 0.18;35.8
Higherfastingglucose§ 13
Dupuisetal.2010,NatGenet50
5%inEFSOCH5,402 3 0.029(0.025,0.032)
mmol/L <2x10-16 0.70;0
Higheroddsofgestationaldiabetesandexistingdiabetes(SNPsassociatedwith
type2diabetes)
55
Morrisetal.2012,NatGenet51
1.4%inALSPAC6,606
(54Cases,6,552controls)
1 Oddsratio:1.08(1.03,1.14) 0.003 -
Highertriglycerides 17 Teslovichetal.2010,Nature52
3%inEFSOCH 663 1 0.055(0.032,0.078)mmol/L 3x10-6 -
LowerHDL-cholesterol 4 Teslovichetal.2010,Nature52
3%inEFSOCH 733 1 -0.050(-0.072,-0.027)mmol/L 1x10-5 -
Highersystolicbloodpressure 33 Ehretetal.2010,
Nature531%inALSPAC 8,450 2 0.186(0.140,0.231)
mmHg <2x10-16 0.04;76.0
LowervitaminDstatus,ln[25(OH)D] 2(“Synthesis”score)¶
Vimaleswaranetal.2013,PloSMed6
0.2%inALSPAC4,767 1 -0.024(-0.039,-
0.009)onlogscale 0.002 -
Loweradiponectin,ln[adiponectin] 3
Yaghootkaretal.2013,Diabetes54
2%inHAPO1,376 1 -0.17(-0.23,-0.11)
onlogscale 1x10-8 -
*Thereferencesincolumn3indicatethepublishedgenome-wideassociationstudiesthatoriginallyidentifiedtheSNPsusedinthegeneticscores(studiesofnon-pregnantindividuals).†Toestimatethevarianceineachtraitexplainedbyitsrespectivegeneticscoreinpregnantwomen(column4),thelargestavailablestudywasused.Abbreviations:ALSPAC,AvonLongitudinalStudyofParentsandChildren33.EFSOCH,ExeterFamilyStudyOfChildhoodHealth40.HAPO,HyperglycemiaandAdversePregnancyOutcomestudy5.FurtherdetailsabouttheincludedstudiescanbefoundineTable4.‡Thedecisiontomodeltheassociationinrelationtothetrait-raisingortrait-loweringalleledependedontheknowndirectionofassociationofeachtraitwithhigherBMI(seeBox1).Column1specifieseachofthesedirectionsofassociation.§Removingtheonestudyinwhichthers10830963SNPwaspoorlyimputed(r2<0.8),weobtainedverysimilarresults(n=4026;effectsize=0.028(95%CI:0.024,0.032);P<2x10-16;Phet=0.46;I2=0%).
30¶ThetwoSNPsselectedforthevitaminDgeneticscorehaveahypothesizedroleinthesynthesisofvitaminD(asopposedtoitsmetabolism)andarerecommendedforuseinMendelianrandomizationstudies.16,17Levelsof25(OH)Dandadiponectinlevelswerelog-transformedtoachievenormalitybeforeanalyses.
31Table3.Associationsbetweenmaternalgeneticscoresandbirthweightofoffspring
Maternaltraitforwhichgeneticscorewas
constructedNstudies TotalN
women
Estimatedchangeinoffspringbirthweight(grams)permaternaltrait-
raising/lowering*allele(95%CI),tothenearest1
gram†
Pvalue
HeterogeneityPValue;I2%frommeta-analysis
Nstudieswithfetalgenotypes
TotalNoffspringwith
genotypesavailable
Estimatedchangeinbirthweight(grams)permaternaltrait-raising/loweringallele*(95%CI),tothenearest1gram†,adjustedforfetal
genotypes
Pvalue(adjustedforfetal
genotypes)
HeterogeneityPValue;I2%frommeta-analysis
(adjustedforfetal
genotypes)
Higherpre-pregnancyBMI 16 25,265 2(0,3) 0.008 0.84;0 7 10,964 4(1,6) 0.004 0.20;30.5
Higherfastingglucose 15 23,902 8(6,10) 7x10-14 0.11;33.3 8 11,493 11(7,14) 7x10-9 0.26;21.6
Higheroddsoftype2Diabetes 12 18,670 2(0,2) 0.06 0.22;23.1 5 7,769 4(2,6) 0.0004 0.81;0
Higheroddsoftype2Diabetes(excludingpre-existingandgestational
diabetes)
6 13,029 2(1,3) 0.02 0.92;0 4 6,210 4(1,6) 0.006 0.93;0
Highertriglycerides 15 24,985 -2(-4,0) 0.12 0.83;0 6 11,031 -2(-7,1) 0.21 0.86;0
LowerHDL-cholesterol 15 22,167 0(-3,3) 1 0.52;0 6 9,176 0(-5,5) 0.98 0.85;0
Highersystolicbloodpressure 13 20,062 -4(-6,-2) 1x10-5 0.14;30.4 5 7,790 -3(-6,0) 0.09 0.50;0
Highersystolicbloodpressure(excludingpre-
eclampsiaandhypertension)
7 13,271 -5(-7,-3) 6x10-6 0.18;32 4 5,488 -4(-8,0) 0.04 0.16;41.2
LowervitaminDstatus 18 30,340 -6(-12,0) 0.03 0.13;37.1 3 9,510 -14(-25,3) 0.01 0.77;0
Loweradiponectin 9 14,920 -2(-16,12) 0.76 0.90;0 5 7,820 7(-16,30) 0.55 0.71;0
*Thedecisiontomodeltheassociationinrelationtothetrait-raisingortrait-loweringalleledependedontheknowndirectionofassociationofeachtraitwithhigherBMI(seeBox1).Column1specifieseachofthesedirectionsofassociation.Resultsareperaverageweightedallele,adjustedforsexandgestationalage.†StandarddeviationofbirthweightaveragedoveranumberofEuropeanstudies(=484g)55wasusedtogeneratetheseestimatesfromz-scores.Weconsidereda2-tailedPvalueof<0.05toprovideevidenceagainstthenullhypothesis.
32
33Table4.Acomparisonoftheobservationalwiththegeneticassociationbetweeneachmaternaltraitandoffspringbirthweight
Maternaltrait Valueofa1SDchangeinthetraitwithunits
Study/ies*usedforobservationalestimates
[TotalNwomen]
Nwomenforobservationalestimates
Observationalestimateofthechangeinbirth
weight(g)per1SD(or10%†)changein
maternaltrait,adjustedforsexand
gestationalage(95%CI)
Geneticestimateofthechangeinbirthweight(g),adjusted
forsexandgestationalage,per1SD(or10%†)changeinmaternaltrait,unadjustedfor
fetalgenotype(95%CI)[NwomenasinTables
1and2]
Pvalue‡comparing
observationalwithgeneticbirth
weightassociations(unadjustedforfetalgenotype)
Geneticestimateofthechangeinbirthweight(g),adjusted
forsex,gestationalageandfetalgenotype,per1SD(or10%†)changeinmaternaltrait(95%CI)[N
offspringasinTables1and2]
Pvalue‡comparing
observationalwithgeneticbirth
weightassociations(adjustedfor
fetalgenotype)
Higherpre-pregnancyBMI 4kg/m2
ALSPACMothers,EFSOCHMothers,HAPO
Mothers11,969 62(56,70) 55(17,93) 0.70 104(32,176) 0.28
Higherfastingglucose 0.4mmol/L EFSOCHMothers,HAPO
Mothers 6,008 92(80,104) 114(80,147) 0.28 145(91,199) 0.09
Highertriglycerides 0.7mmol/L EFSOCHMothers 930 32(7,56) -24(-55,8) 0.007 -33(-86,20) 0.03
LowerHDL-cholesterol 0.5mmol/L EFSOCHMothers 927 30(3,58) 0(-33,34) 0.17 -1(-55,54) 0.32
Highersystolicbloodpressure 10mmHg ALSPACMothers,HAPO
Mothers 12,077 24(15,34) -208(-394,-21) 0.01 -151(-390,89) 0.14
LowervitaminDstatus 10%† ALSPACMothers 4,710 -4(-7,-2) -26(-54,2) 0.13 -56(-112,1) 0.07
Loweradiponectin 10%† HAPOMothers(GWASonly) 1,376 14(9,18) -1(-9,7) 0.002 4(-9,17) 0.19
*Heterogeneitystatisticsfromthemeta-analysesofobservationalassociationswere:Phet=0.03andI2=67.7%forBMI;Phet=0.09andI2=59.1%forfastingglucose;Phet=0.54andI2=0%forSBP.† For25[OH]Dandadiponectin,wepresenttheestimatedchangeinbirthweightper10%reductioninmaternaltraitlevelbecausethesevariableswereloggedforanalysis.‡P-values<0.05areconsideredtoindicateevidencethatthegeneticeffectsizeestimateisdifferentfromtheobservationalestimate,suggestingthattheobservationalestimateissubjecttoconfoundingorbias.ALSPAC:AvonLongitudinalStudyofParentsAndChildren33;EFSOCH:ExeterFamilyStudyofChildhoodHealth40;HAPO:HyperglycaemiaandAdversePregnancyOutcomes5;SDstandarddeviation